Skip to content
Trouver

Medicine in DR Congo · official US FDA label

Micolin 2%

Nitrate de miconazole (miconazole) · crème topique

Authorized in DR Congo

Want to buy it?

Not in stock in our pharmacies right now. Trouver shows when it is back near you. The reservation pages are in French.

See the pharmacies

This is a US label.

The official US FDA label for miconazole (published as MICONAZOLE NITRATE), effective October 3, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.

Official US FDA label for miconazole

Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.

Uses

Stop use and askadoctor if irritation occurs or if there is no improvement within 4 weeks for athlete's foot and ringworm-irritation occurs or if there is no improvementwithin 2 weeks for jock itch

Dosage

US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.

clean the affected area and drythoroughlyapplya thin layer of the product over affected area twicedaily (moming and night) or asdirected byadoctorsupervise children in the use of this productforathlete'sfoot: pay specialattention to spacesbetween the toes; wear well-fitting,ventilatedshoes, and change shoes and socks at leastoncedaily for athlete's foot and ringworm, use dailyfor4weeks; forjock itch, use daily for 2 weeks if condition persists longer, consult a doctor thisproductis noteffective on the scalp ornails

Warnings and precautions

Warnings: For external use only. Donotusebyadoctor · on children under 2 years of age unless directed

Where to find it in DR Congo

Not in stock in our pharmacies right now

Stock changes with every sale. Search by substance: a medicine with the same composition may be available.

Composition

SubstanceStrengthATC code
NITRATE DE MICONAZOLE (miconazole)2%—

Marketing authorization in DR Congo

From the register of the ACOREP (the Congolese pharmaceutical regulatory authority).

  • Authorization number

    MS.1253/10/05/DGM/0329/2021

    Valid from February 17, 2021 until February 17, 2026

    Holder
    UNIQUE PHARMAAv. de Bakongo n° 17C/Gombe
    Manufacturer
    Lincoln Pharmaceuticals Limited Trimul Estate, Khatraj, Tal. Kalol, Dist. Gandhinagar, gujarat, India
    Country
    Inde

Sources

  • ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
  • ●English names of substances: RxNorm, U.S. National Library of Medicine.
  • ●Marketing authorizations: register of the ACOREP, DR Congo, version of February 4, 2026.

Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.